Medipharm Labs Archives | Page 2 of 6

MediPharm Labs Posts Revenues Of $5.5 Million, Net Loss Of $13.9 Million

MediPharm Labs (TSX: LABS) this morning continued its recent trend of dismal financing results, posting revenues of just $5.5 million

Earlier this week, Medipharm Labs (TSX: LABS) reported their fourth quarter and 2020 year-end financial results. The company announced revenue

Medipharm Labs (TSX: LABS) this morning reported its fourth quarter financial results for 2020. Revenues for the quarter amounted to

Medipharm Labs (TSX: LABS) has closed the bought deal financing that it announced and then later upsized earlier this week.

Medipharm Labs (TSX: LABS) has increased the size of the bought deal financing announced last night. Originally pegged at $20.0

Medipharm Labs (TSX: LABS) this evening announced that it will be conducting a bought deal financing. The financing will see

Medipharm Labs (TSX: LABS) this morning finally appointed a new chief financial officer, more than two months after the announced

Medipharm Labs (TSX: LABS) this morning announced drastic changes to its leadership role, with the major change being that CEO

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported revenues came in at $4.9

It appears that not all operators are able to successfully perform under the changing market conditions within the cannabis landscape.